Mineralys Therapeutics, Inc. (MLYS) - What Are Researchers Thinking About This Stock?Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has been assigned an average recommendation of "Hold" from the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold reco...